Steven A. Pergam, MD, MPH

Associate Professor
Fred Hutchinson Cancer Research Center

Disclosure: Chimerix, Inc (Individual(s) Involved: Self): Scientific Research Study Investigator; Global Life Technologies, Inc. (Individual(s) Involved: Self): Research Grant or Support; Merck & Co. (Individual(s) Involved: Self): Scientific Research Study Investigator; Sanofi-Aventis (Individual(s) Involved: Self): Other Financial or Material Support, Participate in clinical trial sponsored by NIAID (U01-AI132004); vaccines for this trial are provided by Sanofi-Aventis

Presentation(s):

• 139 - association of Physician Orders for Life-sustaining Treatment (POLST) with Antimicrobial Use at End of Life in Cancer Patients: An Antimicrobial Stewardship Opportunity

  Oral Abstract